Rybrevant (amivantamab-vmjw)

amivantamab-vmjw · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rybrevant (amivantamab-vmjw), covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Premedication to Reduce Amivantamab Associated Infusion Related Reactions [Phase 2]